Actavis Chairman Joins Zoetis Board Under Deal With Activist Investor Ackman

Pfizer spinoff Zoetis, the animal health company, added a second director to its board under a deal it reached earlier this year with activist investor Bill Ackman and his firm Pershing Square Capital Management...
Login to comment.